ResearcherPage View Count

Geo Map
Region#
AS - Asia3033
EU - Europe915
NA - North America655
HKU - The University of Hong Kong541
AF - Africa88
OC - Oceania7
SA - South America5
UND - Undefined34
Total5278
Country#
CN - China2377
US - United States615
HKU - The University of Hong Kong541
GB - United Kingdom447
KR - Republic of Korea309
HK - Hong Kong248
FR - France185
DE - Germany77
NG - Nigeria67
NL - Netherlands62
OTH - Others350
Total5278
City#
Beijing753
The University of Hong Kong541
Shenzhen339
Nanjing228
Ashburn150
Zhengzhou147
Central District128
Chongqing118
Shanghai103
Clarks Summit93
Others2678
Total5278
Study Site Standard Operating Procedure SOP: S7 - Staff reviews55
Study Site Standard Operating Procedure SOP: S5 - Induction programme for new employees91
Body mass index is different in normal Chinese and caucasian infants75
Body Mass Index is Different in Normal Chinese and Caucasian Infants77
Body mass index is different in normal Chinese and Caucasian infants106
Study Site Standard Operating Procedure SOP: QA6 - Confidentiality agreement, obligations and practices73
Study Site Standard Operating Procedure SOP: T3 Obtaining Written Informed Consent95
Study Site Standard Operating Procedure SOP: T11 - Preparing and managing source documents55
Study Site Standard Operating Procedure SOP: P2 Review Of Protocol66
Study Site Standard Operating Procedure SOP: S3 - Staff responsibilities, duties and job descriptions69
Study Site Standard Operating Procedure SOP: T15 Adverse Event and Serious Adverse Event Reporting108
Study Site Standard Operating Procedure SOP: QA10 - Conflict of interest resolution82
Study Site Standard Operating Procedure SOP: QA4 - Human research protection program54
Study Site Standard Operating Procedure SOP: P11 Investigators' Meeting and Good Clinical Practice Training73
Study Site Standard Operating Procedure SOP: T7 - Remote data capture60
Clinical Trial Protocol Development - Essential Elements Highlight40
Study site standard operating procedures125
Study Site Standard Operating Procedure SOP: QA7 - Participant’s complains71
Study Site Standard Operating Procedure SOP: P3 review of protocol amendments63
Study Site Standard Operating Procedure SOP: QA5 - Fraud and misconduct76
Study Site Standard Operating Procedure SOP: P9 Pre-study Planning of Investigational Products66
Nutritional Status in Hong Kong Chinese Infants in the First Two Years of Life73
Study Site Standard Operating Procedure SOP: T17 Data and Safety Monitoring Committee85
Study Site Standard Operating Procedure SOP: P1 Pre-Study Visit101
Study Site Standard Operating Procedure SOP: P14 - Vulnerable subjects60
Study Site Standard Operating Procedure SOP: T2 Subject Recruitment to Enrollment93
Study Site Standard Operating Procedure SOP: P5 Review of Case Report Form (CRF)94
Linear growth in early childhood in children with congenital hypothyrodism62
Study Site Standard Operating Procedure SOP: T8 - Data clarification56
Study Site Standard Operating Procedure SOP: P7 - Study team: definition of responsibilities64
Study Site Standard Operating Procedure SOP: P4 Review of Investigator’s Brochure70
Study Site Standard Operating Procedure SOP: T12 - Records retention52
Quality Control for Sponsored and Investigator-initiated Clinical Studies38
Study Site Standard Operating Procedure SOP: T6 Paper Case Report Form Completion86
Study Site Standard Operating Procedure SOP: T16 Study Interim Data Analyses and Reports77
Body mass index is different in normal chinese and caucasian infants120
Study Site Standard Operating Procedure SOP: T5 Blinding - Codes And Code Breaking81
Study Site Standard Operating Procedure SOP: QA11 - Feasibility study106
The Clinical Trials Centre at The University of Hong Kong: A Modern Academic Organization in Asia118
Growth and Nutrition in Southern Chinese Infants72
Study Site Standard Operating Procedure SOP: T1 Initiation Visit98
Study Site Standard Operating Procedure SOP: QA12 - Dissemination of study results68
Study Site Standard Operating Procedure SOP: S8 - Staff meetings71
Study Site Standard Operating Procedure SOP: S4 - Staff education and documentation47
The energy and protein intake of Hong Kong Chinese infants in the early life70
Study Site Standard Operating Procedure SOP: S6 - Staff communication principles83
Study Site Standard Operating Procedure SOP: P8 - Recruitment of subjects48
Study Site Standard Operating Procedure SOP: P10 Pre-study Planning for Laboratory Investigations76
Study Site Standard Operating Procedure SOP: QA2 - Study-specific inspection62
Study Site Standard Operating Procedure SOP: P6 - Study organisation and planning63
Study Site Standard Operating Procedures74
Efficient and Effective Ethics Committee Application for Clinical Trials69
Study Site Standard Operating Procedure SOP: T9 - Randomization68
Study Site Standard Operating Procedure SOP: T18 Protocol Deviations and Violations70
Study Site Standard Operating Procedure SOP: T13 - Specimen collection, handling and shipping.73
Study Site Standard Operating Procedure SOP: QA9 - Trial registry74
Study Site Standard Operating Procedure SOP: QA8 - Emergency resuscitation - Cardiac arrest76
The Study Site SOP Standardization - 4S - Project129
Study Site Standard Operating Procedure SOP: T4 Investigational Products Accounting, Dispensing and Administration77
The Improvement in Growth, Socioeconomic and Health Status in Hong Kong Chinese Infants in the First Two Years of Life - 1967 to 199468
Study Site Standard Operating Procedure SOP: P13 - Regulatory authority applications and documents65
Study Site Standard Operating Procedure SOP: P12 - Application for review by Institutional Review Board and obtaining approval57
Preparing and Updating Study Site Standard Operating Procedures66
Study Site Standard Operating Procedure SOP: T14 Continuing Review/Progress Reports and Communications with IRB59
Serum Growth Factors and the Onset of Childhood Phase of Growth of the Infancy-Childhood-Puberty Growth Model in Normal Healthy Infants52
Study Site Standard Operating Procedure SOP: S2 - Staff CV59
Study Site Standard Operating Procedure SOP: T10 - Monitoring visit49
Onset of significant GH dependence of serum IGF-I and IGF-binding protein 3 concentrations in early life88
Study Site Standard Operating Procedure SOP: S1 - Site description54
Study Site Standard Operating Procedure SOP: QA3 - Preparation, approval, review and maintenance of SOPs65
Standard Operating Procedures - a Trust and not a Must52
The Association of Growth with Onset of Childhood Phase of Growth and Changes in Serum GHBP, IGF-I, IGFBP3 in Early Life60


TotJulAugSepOctNovDecJanFebMarAprMayJun
2014/201582794302581743200212751353219
2015/20169409118414722612292772276173
2016/201776792293328217182635301308445
2017/20187906930125055164204889778888
2018/20191352127396625205185901682866208145
2019/20206021801074611622933800000
Ever5278